Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bradykinin antagonists: development and applications

J M Stewart1

  • 1Department of Biochemistry, University of Colorado Medical School, Denver 80262.

Biopolymers
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

'Transient immediate orthostatic hypotension' is preferable to 'initial' orthostatic hypotension.

Autonomic neuroscience : basic & clinical·2025
Same author

Combination Treatment with Antigen-Specific Dual-Sized Microparticle System Plus Anti-CD3 Immunotherapy Fails to Synergize to Improve Late-Stage Type 1 Diabetes Prevention in Nonobese Diabetic Mice.

ACS biomaterials science & engineering·2020
Same author

Engineering immunomodulatory biomaterials for type 1 diabetes.

Nature reviews. Materials·2020
Same author

First Report of Colletotrichum chlorophyti Infecting Soybean Seed in Arkansas, United States.

Plant disease·2019
Same author

Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors.

Investigational new drugs·2017
Same author

First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors.

Investigational new drugs·2017
Same journal

Methionine Oxidation Stabilizes α-Helices but Attenuates Biological Activity in Amphipathic Peptides.

Biopolymers·2026
Same journal

Untreated Rosehip Powder/Poly(Lactic Acid)/Poly(3-Hydroxybutyrate-Co-4-Hydroxybutyrate) Electrospun Mats for Wound Dressing Applications.

Biopolymers·2026
Same journal

Synthesis, Characterization, and Antidiabetic Evaluation of Sequence-Modified Liraglutide Analogs in a Drosophila melanogaster Model.

Biopolymers·2026
Same journal

Fabrication of an Antibacterial Alginate/Chitosan Hydrogel Dressing Loaded With CuO Nanoparticles for Wound Dressing Applications.

Biopolymers·2026
Same journal

Effect of Chitosan-Alginate Polyelectrolyte Complex Formation and Multilayer Polymer Configuration on the Characteristics of 3D-Printed Metronidazole-Loaded Periodontal Films.

Biopolymers·2026
Same journal

Phenolic Grafting of Oxidized Cellulose Nanofibers Using Ferulic Acid: Structural and Antioxidant Analysis Toward Bioactive Nanomaterials.

Biopolymers·2026
See all related articles

Bradykinin (BK) antagonists have advanced understanding of BK

Area of Science:

  • Biochemistry and Pharmacology
  • Physiology and Pathophysiology

Background:

  • Bradykinin (BK) plays a crucial role in regulating major physiological systems.
  • BK is implicated as an initiator or mediator in numerous pathophysiological conditions.
  • The discovery of BK antagonists has significantly accelerated research into BK biology.

Purpose of the Study:

  • To review the historical development of the kallikrein-kinin field and kinin biology.
  • To discuss the chemistry and development of antagonists targeting B1 and B2 kinin receptors.
  • To present the applications of BK antagonists in biomedical research and potential clinical uses.

Main Methods:

  • Literature review of historical developments in the kallikrein-kinin system.
  • Analysis of the chemistry and design of B1 and B2 kinin receptor antagonists.

Related Experiment Videos

  • Synthesis of information on the research and clinical applications of these antagonists.

    • Main Results:

    • Significant advancements in understanding BK biology are attributed to the development of antagonists.
    • The review covers the historical trajectory and key milestones in kinin research.
    • Details on the chemical properties and developmental pathways of B1 and B2 antagonists are provided.

    Conclusions:

    • Bradykinin antagonists are vital tools for exploring BK's physiological and pathophysiological roles.
    • These antagonists hold promise for various biomedical research applications.
    • Potential clinical applications of bradykinin antagonists are highlighted for future development.